A major American medical organization representing more than 11,000 physicians says there exists “insufficient evidence demonstrating a favorable risk-benefit ratio for the pathway of gender-related endocrine and surgical interventions in children and adolescents.” In a position statement published Tuesday, the American Society of Plastic Surgeons (ASPS) said its view of medical interventions for the treatment of gender dysphoria in minors has “evolved” to its new recommendation that plastic surgeons “delay gender-related breast/chest, genital, and facial surgery until a patient is at least 19 years old.”